Brinzolamide is a carbonic anhydrase inhibitor used to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It is supplied as an active pharmaceutical ingredient for use in pharmaceutical manufacturing.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 138890-62-7
3-((1R,2R)-2-((Dimethylamino)methyl)-1-hydroxycyclohexyl)phenyl beta-D-glucopyranosiduronic acid
O-desmethyltramadol glucuronide impurity
Ibandronate sodium monohydrate
active pharmaceutical ingredient
Ziprasidone hydrochloride monohydrate
active pharmaceutical ingredient
Diethyl(2-(2-phenylbutyroyloxy)ethyl)ammonium dihydrogen citrate
active pharmaceutical ingredient
(S)-4-Hydroxy-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide
Pharmaceutical intermediate for sulfonamide synthesis
(4S)-6-chloro-1,1-dioxo-3,4-dihydro-2H-thieno[3,2-e]thiazin-4-ol
Pharmaceutical intermediate
(4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-3,4-dihydrothieno[3,2-e]thiazine-6-sulfonamide
HCRKCZRJWPKOAR-JTQLQIEISA-N
CCN[C@H]1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC